Nanoparticle vaccine for COVID-19 spurs robust immune response in preclinical tests The novel vaccine technology, developed at Scripps Research, uses virus-like protein nanoparticles to elicit high levels of protective antibodies.
September 21, 2020
LA JOLLA, CA In a new study that demonstrates the promise of a novel vaccine approach for COVID-19, Scripps Research scientist Jiang Zhu, PhD, showed that his protein nanoparticle technology successfully triggered a strong immune response in mice. Zhu, who co-founded the spinoff company Ufovax to commercialize the technology and manufacturing platform, says he hopes to advance the vaccine into clinical trials early next year.
The nanoparticle vaccine technology leverages a unique design that's unlike the majority of other COVID-19 vaccine candidates now in clinical testing. Each nanoparticle in the vaccine mimics the natural ball-like shape of a virus, which the immune system is trained to immediately recognize, explains Zhu, associate professor in the Department of Integrative Structural and Computational Biology.
These microscopic spheres are then studded with spike proteins resembling those of the SARS-CoV-2 virus.
Spike proteins are the tools this virus uses to efficiently attach to and infect healthy cells, so we need the immune system to recognize them as the enemy, Zhu says. Our vaccine design enables immune cells to encounter these proteins in a more natural conformation embedded on a spherical particle so they'll know what to do when they face the virus in real life.
By contrast, most experimental COVID-19 vaccines rely on full-length spike proteins that have been modified to remain stable in the body as they interact with the immune system; they are not connected to a virus-like particle. Thus, they may not generate strong enough of an antibody response to prevent COVID-19, Zhu says.
In his pursuit of a safer and more effective path to COVID-19 immunity, Zhu designed spike proteins and attached them to the spherical protein nanoparticles through an elegant self-assembly process he says will ensure the forming a ball-shape particle of a fixed size and enable efficient vaccine production on an industrial scale.
Notably, as part of their work to optimize the spike protein, he and his team identified a problematic element of the spike called the HR2 stalk, which is a flexible hinge connecting the spike to the virus surface, and decided to delete that segment from spike proteins used in the vaccine.
The scientists then tested the nanoparticle vaccine against the altered spike protein known as S2P that's used in most other vaccines, as well as against their own engineered spike protein. To determine efficacy of each approach, they measured antibody responses in mice.
Zhu's nanoparticle vaccine elicited neutralizing antibodies at levels of up to ten times greater than the S2P spike proteins alone and induced critically needed T-cell immunity. The research appears in bioRxiv, an open-access repository of studies not yet published in a peer-reviewed scientific journal.
Our study provides a promising next-generation COVID-19 vaccine candidate that is ready for evaluation in human trials, Zhu says.
Zhu has previously used his nanoparticle technology to develop investigational vaccines for other infectious diseases including SARS, MERS, HIV, RSV, Ebola, malaria and tuberculosis.
The study, Self-assembling nanoparticles presenting receptor binding domain and stabilized spike as next-generation COVID-19 vaccines, was authored by Linling He, Xiaohe Lin, Ying Wang, Ciril Abraham, Cindy Sou, Timothy Ngo, Yi Zhang, Ian Wilson and Jiang Zhu.
The work was funded by the National Institutes of Health [AI129698 and AI140844] and Ufovax. Ufovax holds exclusive intellectual property rights to the technology and several vaccine products, including for COVID-19.
COVID-19 Zhu, Jiang
Most recent headlines
24/12/2025
What is AI good for? Posted by MTI Film on December 24, 2025
What is AI good for?
What is AI good for?
It's been three years since ChatGPT first cap...
24/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
24/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
24/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
24/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
24/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
24/12/2025
Back to All News
Love, Fights, and Everything in Between: Badly in Love' Returns for Season 2
Entertainment
24 December 2025
GlobalJapan
Link copied t...
24/12/2025
Scripps Research study links sleep variability with sleep apnea and hypertension How consumers' digital activity trackers could enable personalized health s...
23/12/2025
How guilas Cibae as Dominican Winter League Games Are Locally Produced for Glob...
23/12/2025
BitFire's Jim Akimchuk on Supplying Scalability and Customization in the Clo...
23/12/2025
CAMB.AI Enables European Athletics to Offer Multi-Language SupportPlan is to eventually offer translation into all languages spoken in EuropeBy Ken Kerschbaumer...
23/12/2025
Analysis: As sports media values trend negative, scarcity and quality are king By Callum McCarthy, Editor-at-Large
Monday, December 22, 2025 - 14:08
Print ...
23/12/2025
ESPN, Disney, and NBA Return to the Animated Altcast Fray With Second Edition of...
23/12/2025
End the Year on a High Note and Donate to the Sports Broadcasting Fund Today! By Ken Kerschbaumer, Editorial Director
Tuesday, December 23, 2025 - 12:25 pm
...
23/12/2025
The year is winding down, the weather outside is frightful, and it's the perfect time to escape into a story that warms the heart. For listeners looking for...
23/12/2025
A Zeus motor is hot fire tested at L3Harris' Camden, Arkansas, solid rocket ...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Lightware will exhibit several major product innovations at ISE 2026, including the new USB-C BOOSTER-V1, Google Meet. integration for various Taurus UCX models...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Taking the Stage at Carnegie Hall-On a Global Scale Boston Conservatory Orchestra students reflect on their epic concert marking the 80th session of the UN Gene...
23/12/2025
Back to All News
Netflix's The Great Flood and Culinary Class Wars 2 Top Gl...
23/12/2025
Back to All News
Stranger Things By the Numbers: How the Global Phenomenon Shap...
23/12/2025
Experience the power of WO Automation for Radio's newest service, the System Effectiveness Review. Designed to help you achieve more, a System Effectiveness...
23/12/2025
23 Dec 2025
VEON's Beeline Kazakhstan and Rakuten Symphony Collaborate to A...
23/12/2025
Back to All News
How Steamy Can It Get? Single's Inferno' Season 5 Pre...
23/12/2025
Back to All News
33 Million Global Viewers on Netflix Watched Jake Paul vs. Ant...
23/12/2025
New technique lights up where drugs go in the body, cell by cell Scripps Research scientists developed a technique that maps drug binding in individual cells th...
22/12/2025
SVG New Sponsor Spotlight: Presidio's Neerav Shah on the Role of Its Captiva...
22/12/2025
Hitting the bullseye: Sky Sports readies itself for the biggest PDC World Darts ...
22/12/2025
Unique skillset: Bringing new directors to the world of darts at The Worlds with...
22/12/2025
Gravity Media prepares for a flight of fancy with the PDC World Darts Championsh...
22/12/2025
One hundred and eighty: Gravity Media on hitting the production bullseye at the ...
22/12/2025
The Famous Group's Jon Slusser on Fascinating Fans Through Immersive Content...
22/12/2025
ESPN's Meg Aronowitz on Continuing High-Quality Broadcasts of Collegiate Spo...
22/12/2025
ESPN Takes Data-Driven Storytelling to New Heights with MNF Playbook with Next ...
22/12/2025
For a decade, popular German podcast Fest & Flauschig has hosted an annual Chris...
22/12/2025
Paramount Scores Largest Share Increase Among Distributors as Paramount and CBS...
22/12/2025
New multi-year deal integrates Roku's data to fuel Nielsen's measurement suite
Roku gains access to Nielsen's streaming ratings, showing The Roku C...
22/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
22/12/2025
Berklee Wrapped 2025: Our Top News and Stories A look back at a year highlighted by faculty milestones, major film and television projects, Bob Dylan's ho...
22/12/2025
The works of Plato state that when humans have an experience, some level of change occurs in their brain, which is powered by memory - specifically long-term me...
22/12/2025
Partnership integrates complementary satellite data and AI analytics to enhance security, infrastructure, and environmental monitoring solutions for global cust...
22/12/2025
Workflows allow you to create a sequence of planned events which may be added to your template(s) or inserted directly into your sequential or background playli...
Nanoparticle vaccine for COVID-19 spurs robust immune response in preclinical tests The novel vaccine technology, developed at Scripps Research, uses virus-like protein nanoparticles to elicit high levels of protective antibodies.
